Al-Shamasi, A.-A.; Elkaffash, R.; Mohamed, M.; Rayan, M.; Al-Khater, D.; Gadeau, A.-P.; Ahmed, R.; Hasan, A.; Eldassouki, H.; Yalcin, H.C.;
et al. Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. Int. J. Mol. Sci. 2021, 22, 12677.
https://doi.org/10.3390/ijms222312677
AMA Style
Al-Shamasi A-A, Elkaffash R, Mohamed M, Rayan M, Al-Khater D, Gadeau A-P, Ahmed R, Hasan A, Eldassouki H, Yalcin HC,
et al. Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. International Journal of Molecular Sciences. 2021; 22(23):12677.
https://doi.org/10.3390/ijms222312677
Chicago/Turabian Style
Al-Shamasi, Al-Anood, Rozina Elkaffash, Meram Mohamed, Menatallah Rayan, Dhabya Al-Khater, Alain-Pierre Gadeau, Rashid Ahmed, Anwarul Hasan, Hussein Eldassouki, Huseyin Cagatay Yalcin,
and et al. 2021. "Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases" International Journal of Molecular Sciences 22, no. 23: 12677.
https://doi.org/10.3390/ijms222312677
APA Style
Al-Shamasi, A.-A., Elkaffash, R., Mohamed, M., Rayan, M., Al-Khater, D., Gadeau, A.-P., Ahmed, R., Hasan, A., Eldassouki, H., Yalcin, H. C., Abdul-Ghani, M., & Mraiche, F.
(2021). Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. International Journal of Molecular Sciences, 22(23), 12677.
https://doi.org/10.3390/ijms222312677
